Gold tier: mechanically validated evidence, with its primary source.
709 evidence items · page 25 / 29
12.9 per_100_person_yearsThe incidence rate of bacterial infections was 12.9 per 100 person-years among HIV-HBV co-infected patients with HBV-replication > 10,000 copies/mL.
Côte d'Ivoirehépatite B · VIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016
32 %Among hospitalized HIV-positive adults in West Africa, other infections were the underlying cause of hospitalization in 32% of patients.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
2 %Among the 313 HIV antibodies carriers in Ivory Coast from January to December 1987, the frequency of HIV2 infection was 2%.
Côte d'IvoireHIV2observed 1987published 1989PubMedOpenAlexdocument of 10 observations
25.9 %25.9% of imported malaria cases were from the Ivory Coast.
Côte d'IvoirepaludismeHAL · Unilimdocument of 123 observations
11.2 %Among the 1644 cancer patients enrolled, 184 (11.2%) were identified as HIV-infected.
Côte d'Ivoirecancer (non précisé) · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations
2.3 per_100_person-yearsHBsAg seroconversion incidence among regular female blood donors in Abidjan decreased from 2.3 per 100 person-years in 1992–1994 to 0.2 per 100 person-years in 2010–2012.
Côte d'Ivoirehépatite Bobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
49 %Among 65 severe morbidity episodes, invasive bacterial diseases accounted for 32 episodes (49%).
Côte d'Ivoireinvasive bacterial diseasespublished 2007AIDS (London, England)europe_pmcdocument of 9 observations
456 cells/mm3The median baseline CD4 count was 456 cells/mm³.
Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642
35 %Thirty-five percent of patients had encephalomeningitis.
Côte d'Ivoireméningite (non précisée)observed 2008 to 2011published 2017Journal de mycologie medicaleeurope_pmcdocument of 11 observations
10.3 %Among 632 participants from Côte d'Ivoire in a randomized-control trial, 65 (10.3%) were hepatitis B surface antigen (HBsAg)-positive.
Côte d'Ivoirehépatite Bpublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016
18.1 %In a cohort of HIV-infected patients of sub-Saharan African origin, the cumulative incidence of lipodystrophy was 18.1% after 3 years of combined antiretroviral therapy.
Côte d'Ivoirelipodystrophy · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations
24 %Among HIV-infected adults interviewed, 24% could be recommended not to start antiretroviral treatment (ART) because their partner was seropositive.
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations
4.3 %HIV incidence among female sex workers whose usual price was less than 3.50$ in Côte d'Ivoire was 4.3%.
Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988
80.5 %80.5% of patients completed 28 days of antiretroviral chemoprophylaxis.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
70.2 %Among 791 HIV-infected patients, 555 (70.2%) were on antiretroviral therapy.
Côte d'IvoireVIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations
20.8 hoursThe average delay before consultation after HIV exposure was 20.8 hours.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
93.1 %The overall prevalence of Plasmodium infection was 93.1%.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
12.7 %Bacteraemia was detected in 12.7% of afebrile people in Côte d'Ivoire.
Côte d'Ivoirebacteraemiapublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations
Malaria case rates were highest in the 0–4 years old age group and declined with increasing age.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
43 patientsAmong 43 HBeAg-negative HIV/HBV co-infected patients not indicated for ART in Côte d'Ivoire, 17 (40%) consistently had 'infection', 5 (12%) consistently had 'hepatitis', and 21 (48%) fluctuated between phases during follow-up.
Côte d'Ivoirehépatite B · VIH/sidapublished 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations
23 casesAmong 1030 patients randomised into IPT arms in the TEMPRANO trial, 23 had active TB.
Côte d'Ivoireactive TBpublished 2017The international journal of tuberculosis and lung disease : the official journal of the Ieurope_pmcdocument of 3 observations
0.3 per_100_person_weeksThe mean malaria incidence was 0.30 case per 100 person-weeks during the pre-intervention period (August 31, 2016–August 31, 2017).
Côte d'Ivoirepaludismeobserved August 31, 2016–August 31, 2017HAL · Unilimdocument of 122 observations
5.8 yearsParticipants were followed for a median of 5.8 years.
Côte d'IvoireVIH/sidapublished 2022HIV medicineeurope_pmcdocument of 6 observations
10.5 %Among the 95 HIV-2 patients enrolled in the 'success cohort', 10 (10.5%) were reported dead.
Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
73 %HIV RNA less than 50 copies/ml at 24 weeks was observed in 64 of 88 (73%) patients in the combined FZD arms.
Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.